Literature DB >> 21063920

Herpes zoster ophthalmicus.

Srinivasan Sanjay1, Philemon Huang, Raghavan Lavanya.   

Abstract

OPINION STATEMENT: The management of herpes zoster (HZ) usually involves a multidisciplinary approach aiming to reduce complications and morbidity. Patients with herpes zoster ophthalmicus (HZO) are referred to ophthalmologists for prevention or treatment of its potential complications. Without prompt detection and treatment, HZO can lead to substantial visual disability. In our practice, we usually evaluate patients with HZO for corneal complications such as epithelial, stromal, and disciform keratitis; anterior uveitis; necrotizing retinitis; and cranial nerve palsies in relation to the eye. These are acute and usually sight-threatening. We recommend oral acyclovir in conjunction with topical 3% acyclovir ointment, lubricants, and steroids for conjunctival, corneal, and uveal inflammation associated with HZO. Persistent vasculitis and neuritis may result in chronic ocular complications, the most important of which are neurotrophic keratitis, mucus plaque keratitis, and lipid degeneration of corneal scars. Postherpetic complications, especially postherpetic neuralgia (PHN), are observed in well over half of patients with HZO. The severe, debilitating, chronic pain of PHN is treated locally with cold compresses and lidocaine cream (5%). These patients also receive systemic treatment with NSAIDs, and our medical colleagues cooperate in managing their depression and excruciating pain. Pain is the predominant symptom in all phases of HZ disease, being reported by up to 90% of patients. Ocular surgery for HZO-related complications is performed only after adequately stabilizing pre-existing ocular inflammation, raised intraocular pressure, dry eye, neurotrophic keratitis, and lagophthalmos. Cranial nerve palsies are common and most often involve the facial nerve, although palsy of the oculomotor, trochlear, and abducens nerves may occur in isolation or (rarely) simultaneously. In our setting, complete ophthalmoplegia is seen more often than isolated palsies, but recovery is usually complete. Vasculitis within the orbital apex (orbital apex syndrome) or brainstem dysfunction is postulated to be the cause of cranial nerve palsies. A vaccine of a lyophilized preparation of the oka strain of live, attenuated varicella-zoster virus is suggested for patients who are at risk of developing HZ and has been shown to boost immunity against HZ virus in older patients.

Entities:  

Year:  2011        PMID: 21063920     DOI: 10.1007/s11940-010-0098-1

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.972


  46 in total

1.  Direct observation of corneal nerve fibres in neurotrophic keratopathy by confocal biomicroscopy.

Authors:  N Morishige; T Komatsubara; T Chikama; T Nishida
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

2.  Varicella in Americans from NHANES III: implications for control through routine immunization.

Authors:  Paul E Kilgore; Deanna Kruszon-Moran; Jane F Seward; Aisha Jumaan; Frederik P L Van Loon; Bagher Forghani; Geraldine M McQuillan; Melinda Wharton; Laura J Fehrs; Cynthia K Cossen; Stephen C Hadler
Journal:  J Med Virol       Date:  2003       Impact factor: 2.327

3.  Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study.

Authors:  A S C Rice; S Maton
Journal:  Pain       Date:  2001-11       Impact factor: 6.961

4.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Authors:  M N Oxman; M J Levin; G R Johnson; K E Schmader; S E Straus; L D Gelb; R D Arbeit; M S Simberkoff; A A Gershon; L E Davis; A Weinberg; K D Boardman; H M Williams; J Hongyuan Zhang; P N Peduzzi; C E Beisel; V A Morrison; J C Guatelli; P A Brooks; C A Kauffman; C T Pachucki; K M Neuzil; R F Betts; P F Wright; M R Griffin; P Brunell; N E Soto; A R Marques; S K Keay; R P Goodman; D J Cotton; J W Gnann; J Loutit; M Holodniy; W A Keitel; G E Crawford; S-S Yeh; Z Lobo; J F Toney; R N Greenberg; P M Keller; R Harbecke; A R Hayward; M R Irwin; T C Kyriakides; C Y Chan; I S F Chan; W W B Wang; P W Annunziato; J L Silber
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

5.  The burden of Herpes Zoster: a prospective population based study.

Authors:  Fiona T Scott; Robert W Johnson; Mary Leedham-Green; Eleri Davies; W John Edmunds; Judith Breuer
Journal:  Vaccine       Date:  2005-09-30       Impact factor: 3.641

6.  A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia.

Authors:  C P Watson; K L Tyler; D R Bickers; L E Millikan; S Smith; E Coleman
Journal:  Clin Ther       Date:  1993 May-Jun       Impact factor: 3.393

7.  The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS.

Authors:  R E Engstrom; G N Holland; T P Margolis; C Muccioli; J I Lindley; R Belfort; S P Holland; W H Johnston; R A Wolitz; A E Kreiger
Journal:  Ophthalmology       Date:  1994-09       Impact factor: 12.079

Review 8.  Varicella zoster virus infections in children after the introduction of live attenuated varicella vaccine.

Authors:  Marietta Vázquez
Journal:  Curr Opin Pediatr       Date:  2004-02       Impact factor: 2.856

9.  Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial.

Authors:  Stephen D Shafran; Stephen K Tyring; Richard Ashton; Jacque Decroix; Chistine Forszpaniak; Alan Wade; Christian Paulet; Daniel Candaele
Journal:  J Clin Virol       Date:  2004-04       Impact factor: 3.168

10.  Oral acyclovir in the treatment of acute herpes zoster ophthalmicus.

Authors:  L M Cobo; G N Foulks; T Liesegang; J Lass; J E Sutphin; K Wilhelmus; D B Jones; S Chapman; A C Segreti; D H King
Journal:  Ophthalmology       Date:  1986-06       Impact factor: 12.079

View more
  6 in total

Review 1.  [Facial and eye pain - Neurological differential diagnosis].

Authors:  O Kastrup; H-C Diener; C Gaul
Journal:  Ophthalmologe       Date:  2011-12       Impact factor: 1.059

2.  Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they?

Authors:  Barbara P Yawn; Peter Wollan; Jennifer St Sauver
Journal:  Am J Epidemiol       Date:  2011-09-13       Impact factor: 4.897

Review 3.  Eyebrow and Eyelash Alopecia: A Clinical Review.

Authors:  Betty Nguyen; Jamie Katy Hu; Antonella Tosti
Journal:  Am J Clin Dermatol       Date:  2022-10-02       Impact factor: 6.233

Review 4.  Corneal nerves in health and disease.

Authors:  Brittany Simmons Shaheen; May Bakir; Sandeep Jain
Journal:  Surv Ophthalmol       Date:  2014-01-23       Impact factor: 6.048

5.  Varicella-zoster virus keratitis with asymptomatic conjunctival viral shedding in the contralateral eye.

Authors:  Akio Miyakoshi; Masaya Takemoto; Kimiyasu Shiraki; Atsushi Hayashi
Journal:  Case Rep Ophthalmol       Date:  2012-10-06

6.  Management of Cavernous Sinus Thrombosis Following Herpes Zoster Ophthalmicus.

Authors:  Yusuf Mehkri; Jeff A Valisno; Lorena Figueredo Rivas; Jairo Hernandez; Varun Jain; Aisha Elfasi; Justin De Prey; Calvin Hu; Bedirhan Tarhan; Ibrahim S Tuna; Hans H Shuhaiber
Journal:  Cureus       Date:  2022-01-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.